EZ Trans Cell Transfection Reagent (Low Toxicity)

Q: Li Ji offers three transfection reagents. What are the differences among them, and how do their performance levels compare to those of Li**?

A: Our company conducted its own tests and collected customer feedback, arriving at the following conclusions: In terms of efficiency: EZ Trans Plus > Li**2000 ≈ EZ Trans (High Efficiency) > Li**3000 > EZ Trans (Low Toxicity). Regarding toxicity: EZ Trans (Low Toxicity) ≈ Li**3000 < EZ Trans Plus < EZ Trans (High Efficiency) ≈ Li**2000.

Q: The cells we transfected contain antibiotics. Will the antibiotics definitely affect transfection efficiency?

A: If possible, avoid adding antibiotics altogether. In theory, antibiotics should not penetrate cells; however, transfection reagents can increase cell permeability, allowing antibiotics to enter and potentially compromising experimental results.

Q: The protocol specifies using Opti‑MEM to dilute both the plasmid and the transfection reagent. Can 1640 be used instead? Also, why must the plasmid and the transfection reagent be diluted separately before mixing? Couldn’t the transfection reagent simply be added directly to the plasmid solution, mixed, and then diluted with culture medium?

A: EZ Trans cell transfection reagent is a cationic transfection agent that requires specific conditions to form a complex with DNA. At an optimal concentration, it facilitates the efficient entry of well‑structured DNA–cationic complexes into cells. If the two are mixed directly, they tend to rapidly aggregate into polymers with heterogeneous morphologies, potentially exposing the DNA on the surface and hindering its uptake, thereby reducing transfection efficiency. Therefore, the order in which EZ Trans is mixed with DNA is also critical. Most cultured cells are maintained in fetal bovine serum, whose composition is highly complex and not fully characterized. While the components of cell transfection reagents are well defined, it remains uncertain whether they might interact with unknown constituents in fetal bovine serum. In fact, such interactions typically impair transfection performance across most reagents; thus, it is essential to minimize serum interference during the formation of the EZ Trans–DNA complex.

Q: The protocol states, “Assess transfection efficiency within 24–48 hours.” Does this refer to the 24–48 hours after replacing the complex-containing culture medium with serum‑supplemented medium, or to the 24–48 hours following addition of the transfection complex?

A: All times are counted from the moment the EZ Trans-DNA complex comes into contact with the cells.

Q: I’m just asking about direct in vivo transfection in mice. Is your existing protocol based on in vitro methods?

A: Currently, the most commonly used vectors for in vivo transfection are adenovirus, lentivirus, and adeno-associated virus. As far as we know, there have been no reports of directly administering transfection reagents in vivo. The prevailing approach involves culturing cells in vitro, performing transfection and selection, and then injecting the transfected cells into the organism.

Q: The protocol mentions that EZ Trans is used for DNA transfection, but I want to transfect siRNA instead—can this be done?

A: RNA transfection is feasible, but since cytotoxicity varies among cell types, the efficiency of RNA transfection and the resulting experimental outcomes often require optimization. Based on our current data, about half of our customers report successful RNA transfection, while the majority observe suboptimal results. As with liposome‑based transfection, RNA transfection is typically used to study functional mechanisms; the cytotoxicity of the transfection reagent may interfere with the accurate assessment of small RNA functions, so it’s advisable for researchers to conduct preliminary experiments.

Q: The protocol mentions an Optimem medium—can we use your EZ Trans reagent for transfection in CD2 medium?

A: You can use this culture medium, as long as it doesn’t interfere with cell growth. Just make sure to omit serum during the transfection preparation. If you can’t use Opti‑MEM for both formulation and transfection and have to rely on CD2 instead, then use CD2 for both steps; of course, it’s best to run some preliminary experiments.

Q: Low transfection efficiency: Interfering or inhibitory factors are present during the preparation of the DNA–transfection reagent complex.

A: Since serum and antibiotics can interfere with the formation of the DNA–transfection reagent complex, please use antibiotic‑free, serum‑free medium or Opti‑MEM during preparation.

Q: Low transfection efficiency and high cytotoxicity—cell density has not been optimized.

A: During DNA transfection and DNA–siRNA co-transfection, maintain cell confluency at 60%–70%; during siRNA transfection, keep cell confluency around 50%.

Q: How do you determine the transfection efficiency in an experiment?

A: It is recommended to include a positive control, such as green fluorescent protein (GFP), for each transfection.

Q: Low transfection efficiency—leaving the transfection complex at room temperature for an extended period.

A: EZ Trans cell transfection reagent should be stored at 4°C. The optimal incubation conditions for the transfection complex are room temperature for 10–20 minutes; prolonged incubation can significantly reduce transfection efficiency, so please ensure the incubation time does not exceed 20 minutes.

Q: Low transfection efficiency—centrifuge the transfection complex at high speed.

A: When forming the transfection complex, standard protocols recommend vortexing the transfection reagent and DNA or siRNA for a few seconds to generate a highly efficient complex. If you wish to pellet any complexes adhering to the tube walls, be sure to centrifuge at a very low speed—e.g., 80g for 5 seconds.

Q: High cytotoxicity — DNA amount is too high

A: It is recommended to plot a dose–response curve to determine the optimal DNA concentration.

Q: High cytotoxicity—excessive transfection reagent dosage

A: It is recommended to plot a dose–response curve to determine the optimal amount of transfection reagent.

Q: High cytotoxicity—cell condition is poor during transfection.

A: The transfection efficiency of EZ Trans cell transfection reagent is not affected by serum in the culture medium; therefore, we recommend using a complete culture medium containing 10% fetal bovine serum and antibiotics during transfection to optimize cell viability.

Q: High cytotoxicity—antibiotics are added too early during stable transfection.

A: Please add the selection antibiotic 48 hours after transfection.